THE WHAT? Natura &Co achieved significant financial growth in Q3 2024, with revenue reaching R$ 6 billion, an 18.5% year-over-year increase in constant currency.

THE DETAILS  This growth was primarily led by Natura Brazil, which reported a 19.4% increase, and a solid recovery from Avon CFT. The company’s recurring EBITDA rose 52%, reaching R$ 870 million with a margin of 14.6%. Additionally, Natura &Co recognized a non-operating loss of R$ 7.0 billion from Avon’s deconsolidation due to Chapter 11 proceedings, though it did not impact cash flow.

THE WHY? Natura &Co’s impressive Q3 performance reflects the success of its integration strategy, particularly in Latin America, as the company continues to expand its market share and margin recovery.